Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1161/ATVBAHA.114.304108PMID 25341795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor-beta signaling in t cells promotes stabilization of atherosclerotic plaques through an interleukin-17 dependent pathway

  2014cited by this paper
• IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.

  2014cited by this paper
• Association between the type and length of tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.

  2013cited by this paper
• Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension.

  2013cited by this paper
• Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study.

  2013cited by this paper
• Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta‐analysis

  2013cited by this paper
• Neutrophil-Derived Cathelicidin Promotes Adhesion of Classical Monocytes

  2013cited by this paper
• Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients.

  2013cited by this paper
• An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.

  2013cited by this paper
• Risk and predictors of cardiovascular disease in psoriasis: a population‐based study

  2013cited by this paper
• CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction

  2013cited by this paper
• Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK.

  2013cited by this paper
• Transforming Growth Factor–β Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17–Dependent Pathway

  2013cited by this paper
• Psoriasis and atherosclerosis: two plaques, one syndrome?

  2012cited by this paper
• Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis

  2012cited by this paper
• Blockade of Phosphatidylinositol 3-Kinase (PI3K)δ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis

  2012cited by this paper
• To be 17 again--anti-interleukin-17 treatment for psoriasis.

  2012cited by this paper
• Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.

  2012cited by this paper
• Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.

  2012cited by this paper
• Attributable risk estimate of severe psoriasis on major cardiovascular events.

  2011cited by this paper
• Inflammation, Immunity, and Hypertension

  2011cited by this paper
• Functional specialization of interleukin-17 family members.

  2011cited by this paper
• Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

  2011cited by this paper
• CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice.

  2011cited by this paper
• Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction

  2011cited by this paper
• Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.

  2011cited by this paper
• Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

  2010cited by this paper
• Psoriasis and cardiovascular disease

  2010cited by this paper
• Formulary Review of 2 New Biologic Agents: Tocilizumab for Rheumatoid Arthritis and Ustekinumab for Plaque Psoriasis

  2010cited by this paper
• Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in disease

  2010cited by this paper
• Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction

  2010cited by this paper
• Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis.

  2010cited by this paper
• Distribution and Categorization of Left Ventricular Measurements in the General Population: Results From the Population-Based Gutenberg Heart Study

  2010cited by this paper
• Increased carotid artery intima‐media thickness and impaired endothelial function in psoriasis

  2009cited by this paper
• Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

  2009cited by this paper
• Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice1

  2009cited by this paper
• Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1

  2009cited by this paper
• The IL-23/Th17 axis in the immunopathogenesis of psoriasis.

  2009cited by this paper
• Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

  2009cited by this paper
• Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction

  2008cited by this paper
• Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.

  2008cited by this paper
• Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

  2008cited by this paper
• The risk of mortality in patients with psoriasis: results from a population-based study.

  2007cited by this paper
• Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats

  2006cited by this paper
• Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.

  2005cited by this paper
• Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity

  2005cited by this paper
• Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte‐expressed protein

  2004cited by this paper
• Interleukin-17 family members and inflammation.

  2004cited by this paper
• Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17*

  2003cited by this paper
• IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation.

  2003cited by this paper
• Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis

  2002cited by this paper
• Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase

  2002cited by this paper
• Anti–Tumor Necrosis Factor-&agr; Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis

  2002cited by this paper
• Dual Effect of Ceramide on Human Endothelial Cells: Induction of Oxidative Stress and Transcriptional Upregulation of Endothelial Nitric Oxide Synthase

  2002cited by this paper
• Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Vasodilator-Stimulated Phosphoprotein Serine 239 Phosphorylation as a Sensitive Monitor of Defective Nitric Oxide/cGMP Signaling and Endothelial Dysfunction

  2000cited by this paper
• Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

  2000cited by this paper
• Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

  1998cited by this paper
• Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

  1996cited by this paper
• Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance.

  1995cited by this paper
• A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

  1995cited by this paper
• Oral treatment of pustulosis palmo-plantaris with a new retinoid, Ro 10-9359.

  1979cited by this paper
• The hatching rhythm of Polystoma integerrimum, a monogenean from the frog Rana temporaria.

  1978cited by this paper

• Prediction of Targets and Mechanisms of Top Ten Core “Food–Medicine Homologous Traditional Chinese Medicines” in Delaying Vascular Aging: An Integrative Computational Study

  2026cites this paper
• Antagonizing IL-17A Reduces Vascular Inflammation and Attenuates Oxidative Stress Formation but Does Not Significantly Improve Vascular Dysfunction Induced by One Week of Angiotensin II Treatment.

  2026influential citation
• Anxiety in Male Psoriasis Mouse Model Is Mediated by the Interaction between γδ T Cell-Derived IL-17A and Microglia.

  2026cites this paper
• IL-17 as a Therapeutic Target in Cardiovascular Diseases: Mechanistic Insights and Translational Opportunities.

  2025cites this paper
• Comparative analysis of cutaneous features of psoriasis in acute and chronic imiquimod-induced mouse models

  2025cites this paper
• What are mice teaching us about psoriatic arthritis?

  2025cites this paper
• ALKBH5 exacerbates psoriatic dermatitis in mice by promoting angiogenesis

  2025cites this paper
• Neuro-immune axis in atherosclerosis: mechanisms of regulation and therapeutic opportunities

  2025cites this paper
• G-CSF Mediates Increased Renal Neutrophils and Kidney Damage in a Psoriasis Mouse Model

  2025cites this paper
• Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies?

  2025cites this paper
• Bridging worlds: a narrative review of IL-17 at the crossroads of inflammation and thrombosis

  2025cites this paper
• Causal relationship between psoriasis and sudden deafness: a Mendelian randomization study

  2025cites this paper
• Photo-induced nitric oxide modulation in human skin: Impacts of geographic location and seasonality on health and disease.

  2025cites this paper
• The relationship between biological aging and psoriasis: evidence from three observational studies

  2025cites this paper
• Interleukin‐17A‐Related Inflammation Mediates Cardiac Injury in Chronic Relapsing Psoriasis‐Like Mouse Model

  2025cites this paper
• Cardiovascular Disease and Psoriasis

  2025cites this paper
• The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future Prospects

  2025cites this paper
• Obesity and Its Comorbidities: Current Treatment Options, Emerging Biological Mechanisms, Future Perspectives and Challenges

  2025cites this paper
• A Common Genetic Background for Psoriasis and Cardiovascular Diseases: A Narrative Review

  2025cites this paper
• Novel Experimental Approach to Investigate Immune Control of Vascular Function: Co-culture of Murine Aortas With T Lymphocytes or Macrophages

  2025cites this paper
• Cardiometabolic Risk in Psoriatic Arthritis: A Hidden Burden of Inflammation and Metabolic Dysregulation

  2025cites this paper
• Dietary Principles, Interventions and Oxidative Stress in Psoriasis Management: Current and Future Perspectives

  2025cites this paper
• KDM6B inhibition modulates monocyte activation and alleviates IMQ-psoriasis skin inflammation

  2025cites this paper
• PPBP/CXCL7: A Novel Chemokine Linking Psoriasis to Atherosclerosis through Endothelial Mitochondrial Dysfunction.

  2025cites this paper
• Endothelial Dysfunction in Psoriasis: An Integrative Review.

  2024cites this paper
• Enthèses : notions fondamentales

  2024cites this paper
• Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease

  2024cites this paper
• Unveiling IL-17's role: Therapeutic insights and cardiovascular implications.

  2024cites this paper
• Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine

  2024cites this paper
• Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies

  2024cites this paper
• Endothelial IL17RD promotes Western diet-induced aortic myeloid cell infiltration.

  2024cites this paper
• Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis

  2024cites this paper
• Limonin alleviates imiquimod-induced psoriasis-like skin inflammation in mice model by downregulating inflammatory responses

  2024cites this paper
• Chinese medicine as comprehensive therapy for psoriasis: A case report

  2024influential citation
• Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation

  2024cites this paper
• Beta-adrenergic signaling and T-lymphocyte-produced catecholamines are necessary for interleukin 17A synthesis

  2024cites this paper
• Immune and inflammatory mechanisms in hypertension

  2024cites this paper
• TH17/Treg lymphocyte balance is regulated by beta adrenergic and cAMP signaling

  2024cites this paper
• The Potential Anti-psoriatic Effects of Andrographolide: A Comparative Study to Topical Corticosteroids

  2024cites this paper
• Vascular dysfunction and arterial hypertension in experimental celiac disease are mediated by gut-derived inflammation and oxidative stress

  2024cites this paper
• Predictive biomarkers and initial analysis of maternal immune alterations in postpartum preeclampsia reveal an immune-driven pathology

  2024cites this paper
• Etiopathogenesis of Psoriasis: Integration of Proposed Theories

  2024cites this paper
• Entesis: nociones fundamentales

  2024cites this paper
• Different levels of lipids, Hb1Ac and cytokines among patients with coronary artery disease

  2024cites this paper
• Identification of metabolites from the gut microbiota in hypertension via network pharmacology and molecular docking

  2024cites this paper
• Dietary salt, vascular dysfunction, and cognitive impairment.

  2024cites this paper
• Prospective evaluation of cardiovascular risk and mortality in patients with psoriasis: An American population‐based study

  2024cites this paper
• Involvement of IL-17 A/IL-17 Receptor A with Neutrophil Recruitment and the Severity of Coronary Arteritis in Kawasaki Disease

  2024cites this paper
• Psoriasis treatments in the stabilization of atherosclerosis: a systematic review

  2024cites this paper
• The Development of Systemic Inflammatory Diseases in Hidradenitis Suppurativa

  2023cites this paper
• Role of IL-17A in different stages of ischemic stroke.

  2023cites this paper
• Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells

  2023cites this paper
• Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy

  2023cites this paper
• A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease

  2023influential citation
• The Use of Microbial Modifying Therapies to Prevent Psoriasis Exacerbation and Associated Cardiovascular Comorbidity

  2023cites this paper
• Signaling pathways and targeted therapies for psoriasis

  2023cites this paper
• Potential Role of the Skin in Hypertension Risk Through Water Conservation: Salt Series.

  2023cites this paper
• IL-17A-driven psoriasis is critically dependent on IL-36 signaling

  2023cites this paper
• IL‐17A is involved in the hyperplasia of blood vessels in local lesions of psoriasis by inhibiting autophagy

  2023cites this paper
• Inflammatory Bowel Disease Increases the Severity of Myocardial Infarction after Acute Ischemia–Reperfusion Injury in Mice

  2023cites this paper
• Bidirektionale Assoziationen zwischen Psoriasis und Migräne: Eine systematische Übersicht und Metaanalyse

  2023cites this paper
• Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis.

  2023cites this paper
• Kardiovaskuläre Komorbidität bei Psoriasis – Entzündung in Psoriasis betrifft nicht nur die Haut

  2023cites this paper
• Cardiovascular comorbidity in psoriasis – psoriatic inflammation is more than just skin deep

  2023cites this paper
• MMP-2 and its implications on cardiac function and structure: interplay with inflammation in hypertension.

  2023cites this paper
• Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammation

  2023influential citation
• Bidirectional associations between psoriasis and migraine: A systematic review and meta‐analysis

  2023cites this paper
• Insights into Nutritional Strategies in Psoriasis

  2023cites this paper
• Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians

  2023cites this paper
• RUPP Th17s cause hypertension and mitochondrial dysfunction in the kidney and placenta during pregnancy.

  2023cites this paper
• Angiotensin II-induced a steeper blood pressure elevation in IL-23 receptor-deficient mice: Role of interferon-γ-producing T cells

  2022cites this paper
• 2022 Taiwanese Dermatological Association (TDA), Taiwanese Association for Psoriasis and Skin Immunology (TAPSI), and Taiwan Society of cardiology (TSOC) joint consensus recommendations for the management of psoriatic disease with attention to cardiovascular comorbidities.

  2022cites this paper
• Case-Fatality and Temporal Trends in Patients with Psoriasis and End-Stage Renal Disease

  2022cites this paper
• Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways

  2022cites this paper
• Endothelial dysfunction in psoriatic arthritis patients: correlations between insulin resistance and disease activity.

  2022cites this paper
• The relationship between B-cell lymphoma 2, interleukin-1β, interleukin-17, and interleukin-33 and the development of diabetic nephropathy

  2022cites this paper
• Secukinumab for the treatment of adult‐onset pityriasis rubra pilaris: a single‐arm clinical trial with transcriptomic analysis *

  2022cites this paper
• Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time

  2022influential citation
• Otologic Manifestations of Psoriasis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Cardiovascular risk in patients with selected cutaneous diseases

  2022cites this paper
• Erythrodermic Psoriasis in Medico-Legal Practice: An Overview of a Case

  2022cites this paper
• Psoriasis and Systemic Inflammatory Disorders

  2022cites this paper
• 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.

  2022cites this paper
• Interleukin 17, the double-edged sword in atherosclerosis.

  2022cites this paper
• Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis

  2022cites this paper
• Epicutaneous application of Imiquimod to model psoriasis-like skin disease induces water-saving aestivation motifs and vascular inflammation.

  2022cites this paper
• Interleukin 17A infusion has no acute or long-term hypertensive action in conscious unrestrained male mice

  2022influential citation
• Melatonin prevents experimental central serous chorioretinopathy in rats

  2022cites this paper
• Mineralocorticoid receptor blockade with spironolactone has no direct effect on plasma IL-17A and injury markers in urine from kidney transplant patients.

  2021cites this paper
• The Role of IL-17 Cytokines in Psoriasis

  2021cites this paper
• Mouse Models of Psoriasis: A Comprehensive Review.

  2021cites this paper
• The Relationship between IL-1β, IL-17, IL-33 and Bcl-2 and the Development of Diabetic Nephropathy

  2021cites this paper
• Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis

  2021influential citation
• Nomogram for accurate and quantitative prediction of the risk of psoriatic arthritis in Chinese adult patients with moderate and severe plaque psoriasis

  2021cites this paper
• Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics

  2021cites this paper
• Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches

  2021cites this paper
• Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities

  2021cites this paper
• Myeloid cells, tissue homeostasis, and anatomical barriers as innate immune effectors in arterial hypertension

  2021cites this paper
• Interleukin-17A: Potential mediator and therapeutic target in hypertension.

  2021cites this paper
• New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

  2021influential citation